Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05308706 · ClinicalTrials.gov registry record · NA
Efficacy of the Apollo System for Children With ADHD
A NA study, sponsored by Michigan State University.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05308706: Active NA study, sponsored by Michigan State University.
NCT05308706 is a NA study that is active but no longer recruiting, run by Michigan State University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05308706, a NA study, is active but no longer recruiting, sponsored by Michigan State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
To determine the extent to which the Apollo System is effective in reducing symptomatology associated with ADHD.
Primary Outcome
At pre and posttest, the parents/guardians of participants will complete the ADHD-5 Rating Scale. The behaviors included in the survey are derived from the diagnostic criteria for ADHD established in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Scores are summated into inattentive and hyperactive-impulsive symptom domains and transformed into symptom percentile scores based upon normative data based on age and biological sex. Change in the overall ADHD percentile will
Interventions
- DEVICE 8 weeks of home based use.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-03-18 |
| Est. Completion | 2027-08-15 |
| Phase | NA |
What the registry record for NCT05308706 still lists
NCT05308706 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which 8 weeks of home based use. is the first listed.
NCT05308706 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05308706 about?
NCT05308706 is a clinical study titled "Efficacy of the Apollo System for Children With ADHD". To determine the extent to which the Apollo System is effective in reducing symptomatology associated with ADHD.
What is the current status of trial NCT05308706?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-03-18. Estimated completion is 2027-08-15.
What interventions are being tested in trial NCT05308706?
The interventions under investigation include: 8 weeks of home based use. (DEVICE).
Who is sponsoring clinical trial NCT05308706?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05308706's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI